Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome

Supportive Care in Cancer

Volumn 18, Issue 12, 2010, Pages 1565-1569

  Imataki, Osamu ^a   Kamioka, Takeshi ^b   Fukuda, Takashi ^c   Tanosaki, Ryuji ^a   Takaue, Yoichi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b Nihon Schering KK   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Allogeneic stem cell transplantation (allo SCT); Cost effective analysis (CEA); Medical economics

Indexed keywords

BUSULFAN; CLADRIBINE; CYCLOPHOSPHAMIDE; FLUDARABINE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG COST; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; HOSPITAL COST; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MALE; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SENSITIVITY ANALYSIS; SURVIVAL TIME; WHOLE BODY RADIATION;

ADULT; COST-BENEFIT ANALYSIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LENGTH OF STAY; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY-ADJUSTED LIFE YEARS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOKYO; TRANSPLANTATION CONDITIONING;

EID: 78349304888     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0779-z     Document Type: Article

References (18)

1. J Alamo M Shahjahan HM Lazarus M de Lima SA Giralt 2005 Comorbidity indices in hematopoietic stem cell transplantation: a new report card Bone Marrow Transplant 36 475 479 1:STN:280:DC%2BD2MvmslCitQ%3D%3D 10.1038/sj.bmt.1705041 15995717 (Pubitemid 43118140)
2. EP Alyea HT Kim V Ho, et al. 2006 Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome Biol Blood Marrow Transplant 12 1047 1055 10.1016/j.bbmt.2006.06.003 17067911 (Pubitemid 44603937)
3. EA Copelan 2006 Hematopoietic stem-cell transplantation N Engl J Med 354 1813 1826 1:CAS:528:DC%2BD28XjvVarsro%3D 10.1056/NEJMra052638 16641398
4. C Cordonnier S Maury H Esperou, et al. 2005 Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia Bone Marrow Transplant 36 649 654 1:STN:280:DC%2BD2MvptFGntg%3D%3D 10.1038/sj.bmt.1705109 16044135 (Pubitemid 43115022)
5. S Giralt E Estey M Albitar, et al. 1997 Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 89 4531 4536 1:CAS:528:DyaK2sXjvFCkt7g%3D 9192777
6. T Hamaki M Kami SW Kim, et al. 2004 Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies Bone Marrow Transplant 33 891 900 1:CAS:528:DC%2BD2cXjt1Cmu7c%3D 10.1038/sj.bmt.1704477 15048142 (Pubitemid 38660121)
7. P Jacobs D Hailey R Turner N MacLean 2000 Allogeneic stem cell transplantation. An economic comparison of bone marrow, peripheral blood, and cord blood technologies Int J Technol Assess Health Care 16 874 884 1:STN:280:DC%2BD3cvnslKqsQ%3D%3D 10.1017/S0266462300102144 11028142
8. NA Kernan G Bartsch RC Ash, et al. 1993 Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program N Engl J Med 328 593 602 1:STN:280:DyaK3s7ls1OlsQ%3D%3D 10.1056/NEJM199303043280901 8429851 (Pubitemid 23065358)
9. IF Khouri M Keating M Körbling, et al. 1998 Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol 16 2817 2824 1:STN:280: DyaK1czmvVCgsA%3D%3D 9704734
10. PA McSweeney D Niederwieser JA Shizuru, et al. 2001 Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Blood 97 3390 3400 1:CAS:528:DC%2BD3MXktFOkt7c%3D 10.1182/blood.V97.11.3390 11369628
11. M Pignone S Saha T Hoerger, et al. 2005 Challenges in systematic reviews of economic analyses Ann Intern Med 142 12 Pt 2 1073 1079 15968032
12. AM Saito D Zahrieh C Cutler, et al. 2007 Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy Bone Marrow Transplant 40 209 217 1:STN:280:DC%2BD2svhs12jsg%3D%3D 10.1038/sj.bmt.1705733 17563734 (Pubitemid 47108463)
13. P Satwani L Harrison E Morris G Del Toro MS Cairo 2005 Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges Biol Blood Marrow Transplant 11 403 422 10.1016/j.bbmt.2005.04.002 15931629 (Pubitemid 40753793)
14. S Slavin A Nagler E Naparstek, et al. 1998 Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 91 756 763 1:STN:280: DyaK1c7hvVWrtQ%3D%3D 9446633
15. G Socié JV Stone JR Wingard, et al. 1999 Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects working committee of the international bone marrow transplant registry N Engl J Med 341 14 21 10.1056/NEJM199907013410103 10387937 (Pubitemid 29293715)
16. BM Svahn O Alvin O Ringdén, et al. 2006 Costs of allogeneic hematopoietic stem cell transplantation Transplantation 82 147 153 10.1097/01.tp.0000226171.43943.d3 16858272 (Pubitemid 44126806)
17. PL Weiden KM Sullivan N Flournoy R Storb ED Thomas 1981 Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation N Engl J Med 304 1529 1533 1:STN:280:DyaL3M7pslGnuw%3D%3D 10.1056/NEJM198106183042507 7015133
18. HG Welch EB Larson 1989 Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia N Engl J Med 321 807 812 1:STN:280: DyaL1MzmsFSmtg%3D%3D 10.1056/NEJM198909213211207 2505077